Chinese General Practice ›› 2022, Vol. 25 ›› Issue (15): 1914-1918.DOI: 10.12114/j.issn.1007-9572.2021.02.132
Special Issue: 泌尿系统疾病最新文章合集
• Review • Previous Articles Next Articles
Received:
2021-08-10
Revised:
2021-12-15
Published:
2022-01-27
Online:
2022-04-07
Contact:
Heng JIN
About author:
通讯作者:
靳衡
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.132
肾功能分级 | 肾小球滤过率标准 | 尿量标准 |
---|---|---|
危险 | 血肌酐上升1.5倍或肾小球滤过率下降25%~50% | 尿量<0.5 ml·kg-1 ·h-1,持续6 h |
损伤 | 血肌酐上升2倍或肾小球滤过率下降51%~75% | 尿量<0.5 ml·kg-1 ·h-1,持续12 h |
衰竭 | 血肌酐上升3倍或肾小球滤过率下降>75%或血肌酐≥4 mg/dl或血肌酐急剧上升≥0.5 mg/dl | 尿量<0.3 ml·kg-1 ·h-1,持续24 h或无尿12 h |
丧失 | 持续肾功能完全丧失>4周 | - |
终末期肾病 | 持续肾功能完全丧失>3个月 | - |
Table 1 RIFLE criteria for acute kidney injury
肾功能分级 | 肾小球滤过率标准 | 尿量标准 |
---|---|---|
危险 | 血肌酐上升1.5倍或肾小球滤过率下降25%~50% | 尿量<0.5 ml·kg-1 ·h-1,持续6 h |
损伤 | 血肌酐上升2倍或肾小球滤过率下降51%~75% | 尿量<0.5 ml·kg-1 ·h-1,持续12 h |
衰竭 | 血肌酐上升3倍或肾小球滤过率下降>75%或血肌酐≥4 mg/dl或血肌酐急剧上升≥0.5 mg/dl | 尿量<0.3 ml·kg-1 ·h-1,持续24 h或无尿12 h |
丧失 | 持续肾功能完全丧失>4周 | - |
终末期肾病 | 持续肾功能完全丧失>3个月 | - |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
张雪梅,唐怡,杨莹莹,等. 肌红蛋白诱导的内质网应激及细胞凋亡在挤压综合征中的机制初探[J]. 四川大学学报:医学版,2015,46(1):22-26. DOI:10.13464/j.scuxbyxb.2015.01.005.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[1] | HONG Yuchun, WU Hua, DU Yishan, LI Shuran, SUN Wenmin, YE Mingyu, ZHANG Yongjian, LI Yang. Development of General Practice Diagnostic Terminology and Coding and Empirical Study on Its Application [J]. Chinese General Practice, 2023, 26(31): 3896-3901. |
[2] | WANG Zhen, SHEN Guoqi, LI Yanan, ZHU Yinghua, QIU Hang, ZHENG Di, XU Tongda, LI Wenhua. Development and Validation of a Risk Prediction Model for Contrast-induced Acute Kidney Injury after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(29): 3650-3656. |
[3] | LIU Yu, YUE Ting, YANG Dongyu, ZHAO Zhongting, YANG Jibo, ZHU Tiantian. Research Progress on Mechanism of Autophagy in the Pathogenesis of Rheumatoid Arthritis [J]. Chinese General Practice, 2023, 26(29): 3710-3714. |
[4] | CHEN Jing, ZOU Tao, ZHAO Danqing, XIAO Ziwen, WU Xianqing, Chinese Medical Association Psychosomatic Medicine Branch Perinatal Mental Disorders Collaborative Group. Expert Consensus on Screening, Diagnosis and Treatment of Perinatal Mental Disorders [J]. Chinese General Practice, 2023, 26(28): 3463-3470. |
[5] | WANG Xiaowen, XIAO Tongling, WANG Yi, YANG Ying, XIA Xiaoshuang, LI Xin. Relationship between Homocysteine Level and Acute Kidney Injury in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(26): 3290-3296. |
[6] | YIN Zhaoxia, KONG Chongyu, ZOU Xianhui, LI Chuang, HUANG Yin, FENG Yang, WANG Yunfei, GONG Weijie. Traditional Chinese Medicine Disease Spectrum Analysis in Outpatient Clinics of Contracted Residents by Family Doctors in Shenzhen Community Health Service Centers [J]. Chinese General Practice, 2023, 26(25): 3112-3117. |
[7] | ZHANG Yunxu, WANG Tingting, WEI Junling, XING Yanyun, SU Li. A Newly Discovered Disease Affecting Women's Physical and Mental Health: Research Status and Expert Consensus Interpretation of Persistent Genital Arousal Disorder [J]. Chinese General Practice, 2023, 26(23): 2830-2835. |
[8] | ZHANG Yanjing, SONG Xiaokun. Ideas for the Diagnosis and Treatment of Multisystem Immune-related Adverse Events Caused by Immune Checkpoint Inhibitors [J]. Chinese General Practice, 2023, 26(23): 2930-2935. |
[9] | HU Xiaofei, ZHAO Ping, CAO Tinghua, PENG Lanlan. Study on the Predictive Value of Abdominal Fat Content and Distribution in the Acute Pancreatitis and Its Severity [J]. Chinese General Practice, 2023, 26(21): 2614-2619. |
[10] | SHEN Junxi, ZHU Xing, CHEN Yunzhi, LI Wen. Novel Developments in Lung and Gut Microbiota and Their Cross-talk with the Development of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2023, 26(20): 2548-2554. |
[11] | REN Yumei, XU Min, YE Meilei, ZHANG Qiu, HU Honglin. A Mutation in the Insulin Receptor Substrate 2 Gene May Be Associated with Maturity-onset Diabetes of the Young: a Case Report with Genetic Analysis [J]. Chinese General Practice, 2023, 26(18): 2301-2305. |
[12] | WANG Hai, WANG Zhuoli, PEI Honghong, PAN Longfei. Analysis of Risk Factors and Exploration of Predictors of Serious Cases of COVID-19 in Xi'an during the Period of 2021-2022 [J]. Chinese General Practice, 2023, 26(17): 2132-2137. |
[13] | XU Bixia, YAO Weiguang. Changes in Patient Visits and Associated Determinants in Primary Healthcare Settings in Guangdong: a Grey Relational Analysis [J]. Chinese General Practice, 2023, 26(16): 1965-1971. |
[14] | LI Yafeng. Clinical Manifestations and Experience of Diagnosis and Treatment of Lymphoid Tissue Infection Caused by Pseudomonas Aeruginosa [J]. Chinese General Practice, 2023, 26(15): 1923-1926. |
[15] | Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022) [J]. Chinese General Practice, 2023, 26(14): 1671-1691. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||